Skip to main content

Peer Review reports

From: Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial

Original Submission
22 Aug 2017 Submitted Original manuscript
18 Sep 2017 Reviewed Reviewer Report - Miya Yoshi
27 Sep 2017 Reviewed Reviewer Report - Desiree Deandreis
12 Oct 2017 Author responded Author comments - Lorenzo Tosco
Resubmission - Version 2
12 Oct 2017 Submitted Manuscript version 2
13 Dec 2017 Reviewed Reviewer Report - Miya Yoshi
19 Dec 2017 Reviewed Reviewer Report - Desiree Deandreis
8 Jan 2018 Author responded Author comments - Lorenzo Tosco
Resubmission - Version 3
8 Jan 2018 Submitted Manuscript version 3
16 Mar 2018 Author responded Author comments - Lorenzo Tosco
Resubmission - Version 4
16 Mar 2018 Submitted Manuscript version 4
Publishing
21 Mar 2018 Editorially accepted
2 Apr 2018 Article published 10.1186/s12885-018-4275-z

You can find further information about peer review here.

Back to article page